OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiology of Renal Cell Carcinoma: 2022 Update
Laura Bukavina, Karim Bensalah, Freddie Bray, et al.
European Urology (2022) Vol. 82, Iss. 5, pp. 529-542
Closed Access | Times Cited: 388

Showing 1-25 of 388 citing articles:

Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial
Shankar Siva, Mathias Bressel, Mark Sidhom, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 3, pp. 308-316
Closed Access | Times Cited: 47

Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
T. Powles, Laurence Albigès, Axel Bex, et al.
Annals of Oncology (2024) Vol. 35, Iss. 8, pp. 692-706
Closed Access | Times Cited: 47

Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16515-16515
Open Access | Times Cited: 43

Global epidemiology of kidney cancer
Luigi Cirillo, Samantha Innocenti, Francesca Becherucci
Nephrology Dialysis Transplantation (2024) Vol. 39, Iss. 6, pp. 920-928
Closed Access | Times Cited: 34

Renal cell carcinoma
Matthew R. Young, Francesca Jackson‐Spence, Luis Beltrán, et al.
The Lancet (2024) Vol. 404, Iss. 10451, pp. 476-491
Closed Access | Times Cited: 32

circASAP1 induces renal clear cell carcinoma ferroptosis by binding to HNRNPC and thereby regulating GPX4
Yunfei Wang, Taowei Yang, Qihao Li, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Current use of percutaneous ablation in renal tumors: an analysis of the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy
Benedikt M. Schaarschmidt, Sebastian Zensen, Claudia Kesch, et al.
European Radiology (2025) Vol. 35, Iss. 3, pp. 1723-1731
Open Access | Times Cited: 1

Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance
Sonia Mazumder, Paul J. Higgins, Rohan Samarakoon
Cancers (2023) Vol. 15, Iss. 4, pp. 1316-1316
Open Access | Times Cited: 35

Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies
Valentina Schiavoni, Roberto Campagna, Valentina Pozzi, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3207-3207
Open Access | Times Cited: 32

Ablative Treatments for Small Renal Masses and Management of Recurrences: A Comprehensive Review
Achille Aveta, Vincenzo Iossa, Gianluca Spena, et al.
Life (2024) Vol. 14, Iss. 4, pp. 450-450
Open Access | Times Cited: 14

Sirtuins in kidney diseases: potential mechanism and therapeutic targets
Qi Jin, Fang Ma, Tong‐Tong Liu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10

Advances in the management of renal cell carcinoma
Luisa M. Cardenas, Samantha Sigurdson, Christopher J.D. Wallis, et al.
Canadian Medical Association Journal (2024) Vol. 196, Iss. 7, pp. E235-E240
Open Access | Times Cited: 9

Ambient air pollution and urological cancer risk: A systematic review and meta-analysis of epidemiological evidence
Jinhui Li, Zhengyi Deng, Simon John Christoph Soerensen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9

Cuproptosis: Mechanism, role, and advances in urological malignancies
Jialong Wu, Jide He, Zenan Liu, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1662-1682
Closed Access | Times Cited: 8

miR-9-5p/HMMR regulates the tumorigenesis and progression of clear cell renal cell carcinoma through EMT and JAK1/STAT1 signaling pathway
Xinyang Niu, Dingheng Lu, Weitao Zhan, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1

UroPredict: Machine learning model on real-world data for prediction of kidney cancer recurrence (UroCCR-120)
G. Margue, Loïc Ferrer, Guillaume Etchepare, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 7

Trifecta Outcomes of Robot-Assisted Partial Nephrectomy Using the New Hugo™ RAS System Versus Laparoscopic Partial Nephrectomy
Francesco Prata, Alberto Ragusa, Francesco Tedesco, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 2138-2138
Open Access | Times Cited: 6

Exploring the Link between Oxidative Stress, Selenium Levels, and Obesity in Youth
Teofana Bizerea, Laura Pitulice, Otilia Bizerea-Spiridon, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7276-7276
Open Access | Times Cited: 6

Label-Free SERS of Urine Components: A Powerful Tool for Discriminating Renal Cell Carcinoma through Multivariate Analysis and Machine Learning Techniques
Bogdan Adrian Buhaş, Valentin Toma, Jean‐Baptiste Beauval, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3891-3891
Open Access | Times Cited: 5

Obesity and renal cell carcinoma: Biological mechanisms and perspectives
Neha Venkatesh, Alberto Martini, Jennifer L. McQuade, et al.
Seminars in Cancer Biology (2023) Vol. 94, pp. 21-33
Open Access | Times Cited: 15

The role of [68 Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma: a preliminary study
Caner Civan, Serkan Kuyumcu, Duygu Has Şimşek, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 51, Iss. 3, pp. 852-861
Closed Access | Times Cited: 15

CircPTEN suppresses human clear cell renal carcinoma progression and resistance to mTOR inhibitors by targeting epigenetic modification
Yangyang Zhan, Yang Liu, Rui Yang, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101003-101003
Closed Access | Times Cited: 14

Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma
Alireza Ghoreifi, Ulka N. Vaishampayan, Ming Yin, et al.
JAMA Oncology (2023) Vol. 10, Iss. 2, pp. 240-240
Closed Access | Times Cited: 14

Page 1 - Next Page

Scroll to top